Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder [Phase 2]
Phase 2 clinical trial evaluating the STIRR intervention for people with co-occurring mental illness and substance use disorders; results we…
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Lifestyle Intervention for Weight Gain Management for Patients With Schizophrenia [NA]
A completed clinical trial evaluated a lifestyle intervention to manage weight gain in patients with schizophrenia and obesity, with results…
-
FDA approval · 2013-05-20FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Clozapine from Mylan Pharmaceuticals Inc., indicating approval of a generic Clozapine product. C…
-
EMA withdrawal · 2013-05-17EMA Application withdrawn: Fanaptum (iloperidone) — Vanda Pharmaceuticals Ltd
The EMA withdrew the application for Fanaptum (iloperidone) by Vanda Pharmaceuticals Ltd for schizophrenia.
-
FDA approval · 2013-05-06FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
FDA approved a supplemental application for haloperidol decanoate, a long-acting injectable antipsychotic, from Patriot Pharmaceuticals LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics [Phase 4]
Phase 4 trial assessing efficacy and tolerability of switching to ziprasidone from other antipsychotics in schizophrenia and schizoaffective…
-
CLINICAL_TRIALS research · 2013-05-06Clinical Trial Update: Medication Adherence in Older People With Psychosis [NA]
Clinical trial update on medication adherence in older adults with psychosis; no current status or results are reported.
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia [NA]
Open trial evaluating allopurinol in patients with poorly responsive schizophrenia; completed with results posted in 2013.
-
FDA approval · 2013-04-30FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental NDA for SEROQUEL (quetiapine) filed by H2-Pharma, LLC.
-
FDA approval · 2013-04-30FDA Approved: SEROQUEL XR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for SEROQUEL XR (quetiapine) submitted by AstraZeneca, resulting in changes to the product label…
-
CLINICAL_TRIALS research · 2013-04-23Clinical Trial Update: Effect of Fluvoxamine on Cognition, Behavior, Symptoms and mRNA and Protein Expression in Schizophrenia Patients [NA]
Clinical trial investigating the effects of fluvoxamine on cognition, behavior, symptoms, and mRNA/protein expression in patients with schiz…
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With Schizophrenia [Phase 2]
This Phase 2 study evaluates the pharmacokinetics and safety of paliperidone palmitate in participants with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Melatonin for Prevention of Metabolic Side Effects of Olanzapine [Phase 2]
A Phase 2 clinical trial testing whether melatonin can prevent metabolic side effects from olanzapine in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Treating Thought Problems in Patients With Schizophrenia [NA]
The document provides a status update on a completed clinical trial studying treatments for thought problems in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2013-04-08Clinical Trial Update: Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills [NA]
A completed clinical trial comparing olanzapine and aripiprazole examines the impact on learning vocational skills in individuals with schiz…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian Hospital [NA]
Completed clinical trial assessing strategies to reduce the use of unmodified electroconvulsive therapy in an Indian hospital, across major …
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Study With Information Technology (IT) - Aided Preventive Program in Schizophrenia [NA]
A completed clinical trial conducted by Prague Psychiatric Center evaluated an information-technology–aided preventive program for schizophr…
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Pharmacological Approach to Improve the Outcome of Social Cognition Training [Phase 1]
Phase 1 clinical trial evaluating a pharmacological approach to improve social cognition training in schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Social Cognition and Interaction Training for Improving Social Functioning in People With Schizophrenia [Phase 1]
Phase 1 clinical trial update reporting the completion of a study evaluating Social Cognition and Interaction Training (SCIT) to improve soc…
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis [NA]
Completed clinical trial update from the University of North Carolina at Chapel Hill about a Graduated Recovery Intervention Program to enha…
-
FDA approval · 2013-03-27FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC.
-
CLINICAL_TRIALS trial_result · 2013-03-27Clinical Trial Update: The Use of Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia (The METS Study) [Phase 4]
Phase 4 METS study evaluating metformin for antipsychotic-induced weight gain in schizophrenia; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia [Phase 3]
Phase 3 trial evaluating clozapine augmented with atomoxetine versus clozapine augmented with placebo in chronic resistant schizophrenia; th…
-
CLINICAL_TRIALS trial_result · 2013-03-25Clinical Trial Update: A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis [Phase 3]
A Phase 3 pilot study evaluated risperidone long-acting injectable for patients with recent-onset psychosis associated with schizophrenia. T…
-
FDA label_change · 2013-03-22FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA approved a supplemental application for Clozaril (clozapine) to update its labeling. The change is related to the product's labeling…